Munafa Stock Market Course + Intraday & FNO calls 
Protagonist Therapeutics (PTGX) Technical (Analysis) Reports Protagonist Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Protagonist Therapeutics (PTGX)
Technical Analysis Report for USA stock PTGX Protagonist Therapeutics. Dated: 23 Apr 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock PTGX Protagonist Therapeutics then click here. or read Experts views on Protagonist Therapeutics or Forecast & share price targets of Protagonist Therapeutics
Protagonist Therapeutics Opened at 106.34 and Closed at: 102.62, which is -2.86% of previous session's close. It moved within a range of 102.26 and 106.98
The session was a Bearish session with an average volume of 651500, which is 46.91% of previous session's volumes.
- There is some negative change in the short term trend, but its too soon to jump onto conclusions.
- Even though the stock has fallen, but its mid term trend is positive and in an uptrend.
- Even though the stock has fallen, but its long term trend is positive and in an uptrend.
Support for tomorrow is 100.08 and resistance for tomorrow is 104.8
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 100.93, 99.23 resistance for tomorrow's hourly charts is 105.65, 108.67
10 Day SMA for Protagonist Therapeutics (PTGX) is 103.58 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Protagonist Therapeutics (PTGX) is 103.12 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Protagonist Therapeutics (PTGX) is 95.8 and the stock is trading above these levels. This is a good sign for its mid to long term trend
100 Day SMA is 90.79 and the stock is trading above these levels. This is a good sign for its long term trend
200 Day SMA Protagonist Therapeutics is 78.13 and stock is trading above these levels. This is a good sign for its long term trend
20 DMA of Protagonist Therapeutics is at 103.12 and 200 DMA is at 78.13, while 50 DMA and 100 DMA are at 95.8 and 90.79 respectively
Protagonist Therapeutics (PTGX) moving average of 20 SMA is at 103.12 and 20 EMA is at 102.56
| Date | Closing Price | 20 SMA | 20 EMA |
| 23 Thu Apr | 102.62 | 103.12 | 102.56 |
| 22 Wed Apr | 105.55 | 103.21 | 102.55 |
| 21 Tue Apr | 105.89 | 102.95 | 102.23 |
| 20 Mon Apr | 105.47 | 102.58 | 101.85 |
| 17 Fri Apr | 105.98 | 102.26 | 101.47 |
| 16 Thu Apr | 103.73 | 102.04 | 101 |
Protagonist Therapeutics (PTGX) moving average of 50 SMA is at 95.8 and 50 EMA is at 97.43
| Date | Closing Price | 50 SMA | 50 EMA |
| 23 Thu Apr | 102.62 | 95.8 | 97.43 |
| 22 Wed Apr | 105.55 | 95.42 | 97.22 |
| 21 Tue Apr | 105.89 | 95 | 96.88 |
| 20 Mon Apr | 105.47 | 94.49 | 96.51 |
| 17 Fri Apr | 105.98 | 94.05 | 96.14 |
| 16 Thu Apr | 103.73 | 93.64 | 95.74 |
Protagonist Therapeutics (PTGX) moving average of 100 SMA is at 90.79 and 100 EMA is at 90.88
| Date | Closing Price | 100 SMA | 100 EMA |
| 23 Thu Apr | 102.62 | 90.79 | 90.88 |
| 22 Wed Apr | 105.55 | 90.67 | 90.64 |
| 21 Tue Apr | 105.89 | 90.49 | 90.34 |
| 20 Mon Apr | 105.47 | 90.28 | 90.03 |
| 17 Fri Apr | 105.98 | 90.07 | 89.72 |
| 16 Thu Apr | 103.73 | 89.86 | 89.39 |
Protagonist Therapeutics (PTGX) moving average of 200 SMA is at 78.13 and 200 EMA is at 80.56
| Date | Closing Price | 200 SMA | 200 EMA |
| 23 Thu Apr | 102.62 | 78.13 | 80.56 |
| 22 Wed Apr | 105.55 | 77.86 | 80.34 |
| 21 Tue Apr | 105.89 | 77.59 | 80.09 |
| 20 Mon Apr | 105.47 | 77.32 | 79.83 |
| 17 Fri Apr | 105.98 | 77.04 | 79.57 |
| 16 Thu Apr | 103.73 | 76.79 | 79.3 |
Teleflex Incorporated has performed better than Protagonist Therapeutics in short term. You could have earned much better returns by investing in Teleflex Incorporated, about 23.24% more returns!
Msa Safety has performed better than Protagonist Therapeutics in short term. You could have earned much better returns by investing in Msa Safety, about 2.32% more returns!
Protagonist Therapeutics has performed better than Supernus Pharmaceuticals in short term. Holding Protagonist Therapeutics could be a better choice for now!
Si Bone has performed better than Protagonist Therapeutics in short term. You could have earned much better returns by investing in Si Bone, about 3.92% more returns!
Ptc Therapeutics has performed better than Protagonist Therapeutics in short term. You could have earned much better returns by investing in Ptc Therapeutics, about 1.93% more returns!
Protagonist Therapeutics has performed better than Orasure Technologies in short term. Holding Protagonist Therapeutics could be a better choice for now!
Protagonist Therapeutics has performed better than Novavax Inc in short term. Holding Protagonist Therapeutics could be a better choice for now!
Intellia Therapeutics has performed better than Protagonist Therapeutics in short term. You could have earned much better returns by investing in Intellia Therapeutics, about 19.42% more returns!
Lifevantage Corporation has performed better than Protagonist Therapeutics in short term. You could have earned much better returns by investing in Lifevantage Corporation, about 15.18% more returns!
Kalvista Pharmaceuticals has performed better than Protagonist Therapeutics in short term. You could have earned much better returns by investing in Kalvista Pharmaceuticals, about 0.19% more returns!
Inogen Inc has performed better than Protagonist Therapeutics in short term. You could have earned much better returns by investing in Inogen Inc, about 7.1% more returns!
Protagonist Therapeutics has performed better than Idexx Laboratories in short term. Holding Protagonist Therapeutics could be a better choice for now!
Heron Therapeutics has performed better than Protagonist Therapeutics in short term. You could have earned much better returns by investing in Heron Therapeutics, about 20.04% more returns!
Protagonist Therapeutics has performed better than Co Diagnostics in short term. Holding Protagonist Therapeutics could be a better choice for now!
Chemocentryx Inc has performed better than Protagonist Therapeutics in short term. You could have earned much better returns by investing in Chemocentryx Inc, about 0.35% more returns!
Biolife Solutions has performed better than Protagonist Therapeutics in short term. You could have earned much better returns by investing in Biolife Solutions, about 10.09% more returns!
Protagonist Therapeutics has performed better than Allogene Therapeutics in short term. Holding Protagonist Therapeutics could be a better choice for now!
Protagonist Therapeutics Technical analysis of indicators
Price action analysis of Protagonist Therapeutics (PTGX) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Protagonist Therapeutics stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Protagonist Therapeutics in short term but the sell signal is initial and weak.
Protagonist Therapeutics Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Protagonist Therapeutics in short term but SELL signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Protagonist Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 103.26 and Protagonist Therapeutics PTGX stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Protagonist Therapeutics PTGX stock. Volume based technical analysis of Protagonist Therapeutics PTGX stock is negative.
Protagonist Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock PTGX Protagonist Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And PTGX Experts View which covers a lot of information including buying and selling signals
PTGX future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Protagonist Therapeutics or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Protagonist Therapeutics (PTGX) Technical (Analysis) Reports Protagonist Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Basics How To Trade In FnO Futures Options Stock Market
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance
